Clinical Trials

7 enrolled 6 charts

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis

NCT01190241 2020-11-20

TSAP

Phase NA Terminated

45 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01118975 2019-11-13

GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers

Phase 1/2 Terminated

12 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01891357 2019-09-17

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

64 enrolled 7 charts

Carcinoma, Ductal, Breast

NCT00759642 2019-07-01

Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy

33 enrolled 7 charts

Breast Neoplasms

NCT00225758 2018-07-27

Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy

27 enrolled 5 charts

Breast Neoplasms

NCT01934894 2017-07-02

Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases

11 enrolled 7 charts

Metastatic Breast Cancer With Intracranial Metastases

NCT01868503 2017-06-26

Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer

7 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00496366 2017-03-21

Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer

11 enrolled 8 charts

Breast Neoplasms

NCT00490061 2017-03-06

Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

17 enrolled 7 charts

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01769508 2016-06-13

Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer

12 enrolled 8 charts

Gastrointestinal

HER2 Positive Esophagogastric Cancer

NCT01497626 2016-02-17

Lapatinib and Bortezomib in Patients With Advanced Malignancies

15 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT01534455 2016-02-10

Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)

43 enrolled

Breast Neoplasms

NCT02131506 2016-02-02

CAELYX

11 enrolled

Breast Neoplasms

NCT00754702 2015-09-28

Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer

16 enrolled

Breast Neoplasms

NCT01161368 2015-08-13

A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients

9 enrolled

Breast Neoplasms

NCT00857714 2015-07-08

Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast

Phase NA Terminated

1 enrolled 9 charts

Phase EARLY_PHASE1 Terminated

Carcinoma, Intraductal, Noninfiltrating

NCT01427322 2015-07-08

Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease

6 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01666431 2014-12-03

Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment

10 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT01238029 2014-11-21

CELAVIE

12 enrolled

Breast Neoplasms

NCT00756470 2014-11-17

Phase II Neoadjuvant in Inflammatory Breast Cancer

15 enrolled 10 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01145404 2014-07-02

GastroLap

76 enrolled

Gastrointestinal

GastroEsophageal Cancer

NCT01477060 2014-02-20

Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer

32 enrolled

Breast Neoplasms

NCT00903656 2013-12-24

Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy

24 enrolled

Breast Neoplasms

NCT01658358 2013-02-27

ErbB2 Positive Metastatic Breast Cancer

Phase 1/2 Terminated

15 enrolled

Phase EARLY_PHASE1 Terminated

Breast Neoplasms

NCT01245660 2013-01-11

LAPAINBLAD

3 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00499681 2012-08-10

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

6 enrolled 8 charts

Breast Neoplasms

NCT00317434 2009-12-15

Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer

12 enrolled

Gynecologic

Ovarian Neoplasms

NCT00888810 2009-04-28

TOPO-LAPA

39 enrolled

Neoplasms, Recurrence

NCT00239200 2008-07-30

Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus